Kilitch Drugs (India) Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 16.08 Cr
as on 15-11-2024
- Company Age 32 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 140.39 Cr
as on 15-11-2024
- Satisfied Charges ₹ 171.09 Cr
as on 15-11-2024
- Revenue 11.54%
(FY 2023)
- Profit 49.29%
(FY 2023)
- Ebitda 73.39%
(FY 2023)
- Net Worth 10.05%
(FY 2023)
- Total Assets 8.66%
(FY 2023)
About Kilitch Drugs (India)
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524500 and on the National Stock Exchange(NSE) under KILITCH.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 16.08 Cr.
The company currently has active open charges totaling ₹140.39 Cr. The company has closed loans amounting to ₹171.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Kilitch Drugs (India) Limited. India are Sunil Jain as CFO and Pushpa Nyoupane as Company Secretary. Mukund Mehta, Vasudev Krishnamurti, Mira Mehta, and Four other members serve as directors at the Company.
Industry
Company Details
- LocationThane, Maharashtra
- Telephone
- Email Address
- Website
- Social Media
What products or services does Kilitch Drugs (India) Limited. offer?
Kilitch Drugs (India) Limited. offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Infective Agent, Common Disease Medicines, Cough Syrup, Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections, Dyes & Color Additives, Cobaltous Nitrate, Anti Cancer Medicines, Oncology Drug.
Who are the key members and board of directors at Kilitch Drugs (India)?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukund Mehta  | Managing Director | 12-May-1992 | Current |
| Mira Mehta | Managing Director | 17-Oct-2013 | Current |
| Sunil Jain | CFO | 01-Mar-2021 | Current |
| Pushpa Nyoupane | Company Secretary | 05-May-2022 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hemang Engineer | Director | 30-Jun-2008 | Current |
| Vasudev Krishnamurti | Director | 16-Mar-2018 | Current |
| Dipen Jain | Director | 24-Oct-2024 | Current |
| Bhavin Mehta | Whole-Time Director | 30-Sep-2000 | Current |
| Venkita Rajan | Director | 28-Jun-2018 | Current |
Financial Performance and Corporate Structure Insights of Kilitch Drugs (India).
Kilitch Drugs (India) Limited., for the financial year ended 2023, experienced significant growth in revenue, with a 11.54% increase. The company also saw a substantial improvement in profitability, with a 49.29% increase in profit. The company's net worth Soared by an impressive increase of 10.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kilitch Drugs (India)?
In 2022, Kilitch Drugs (India) had a promoter holding of 68.24% and a public holding of 31.75%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kilitch Company (Pharma) LimitedActive 41 years 4 monthsMukund Mehta, Mira Mehta and 1 more are mutual person
Indo Ethiopian Chamber Of Commerce And IndustryActive 4 years 1 monthMukund Mehta and Venkita Rajan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 21 Nov 2023 | ₹50.00 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Oct 2023 | ₹50.00 Cr | Open |
Standard Chartered Bank Creation Date: 03 Oct 2022 | ₹7.50 M | Open |
How Many Employees Work at Kilitch Drugs (India)?
Kilitch Drugs (India) has a workforce of 152 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kilitch Drugs (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kilitch Drugs (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
